ProfileGDS4718 / 233809_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 50% 46% 52% 49% 51% 53% 54% 53% 42% 55% 49% 56% 50% 55% 47% 50% 51% 57% 62% 55% 48% 46% 52% 48% 53% 50% 52% 48% 62% 57% 53% 49% 47% 49% 52% 56% 50% 52% 45% 49% 49% 49% 50% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5159850
GSM549102patient 115, normal, homogenized [OPG study]5.5180250
GSM549104patient 119, normal, homogenized [OPG study]5.2796646
GSM549108patient 138, normal, homogenized [OPG study]5.6516952
GSM549119patient 077, normal, homogenized [OPG study]5.4885749
GSM549133patient 032, cancer, homogenized [OPG study]5.5507451
GSM549139patient 042, cancer, homogenized [OPG study]5.6929353
GSM549099patient 107, normal, homogenized [OPG study]5.7332654
GSM549109patient 139, normal, homogenized [OPG study]5.7330953
GSM549110patient 046, normal, homogenized [OPG study]5.1073642
GSM549114patient 063, normal, homogenized [OPG study]5.7362655
GSM549122patient 082, normal, homogenized [OPG study]5.4754849
GSM549134patient 033, cancer, homogenized [OPG study]5.8310356
GSM549136patient 036, cancer, homogenized [OPG study]5.4621750
GSM549140patient 044, cancer, homogenized [OPG study]5.7911555
GSM549111patient 047, normal, homogenized [OPG study]5.3252947
GSM549113patient 057, normal, homogenized [OPG study]5.4741450
GSM549132patient 031, cancer, homogenized [OPG study]5.557451
GSM549137patient 038, cancer, homogenized [OPG study]5.9091657
GSM549142patient 047, cancer, homogenized [OPG study]6.35162
GSM549100patient 110, normal, homogenized [OPG study]5.8281455
GSM549107patient 135, normal, homogenized [OPG study]5.3534648
GSM549115patient 068, normal, homogenized [OPG study]5.2359546
GSM549116patient 072, normal, homogenized [OPG study]5.6165752
GSM549120patient 078, normal, homogenized [OPG study]5.4041748
GSM549131patient 030, cancer, homogenized [OPG study]5.660553
GSM549118patient 074, normal, homogenized [OPG study]5.5205950
GSM549129patient 027, cancer, homogenized [OPG study]5.6423752
GSM549123patient 088, normal, homogenized [OPG study]5.379448
GSM549124patient 006, cancer, homogenized [OPG study]6.2306362
GSM549126patient 015, cancer, homogenized [OPG study]5.8886557
GSM549128patient 025, cancer, homogenized [OPG study]5.7019553
GSM549103patient 117, normal, homogenized [OPG study]5.5105749
GSM549117patient 073, normal, homogenized [OPG study]5.3056847
GSM549138patient 041, cancer, homogenized [OPG study]5.4771149
GSM549141patient 045, cancer, homogenized [OPG study]5.605952
GSM549130patient 028, cancer, homogenized [OPG study]5.8919756
GSM549101patient 111, normal, homogenized [OPG study]5.5368550
GSM549105patient 128, normal, homogenized [OPG study]5.628152
GSM549106patient 134, normal, homogenized [OPG study]5.1719745
GSM549112patient 048, normal, homogenized [OPG study]5.4255549
GSM549125patient 011, cancer, homogenized [OPG study]5.4639249
GSM549127patient 024, cancer, homogenized [OPG study]5.4394849
GSM549135patient 035, cancer, homogenized [OPG study]5.4684950